A5030008007- Reproductive Health and Contraception
- Male Reproductive Health Studies
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Maternal and Neonatal Healthcare
- Intimate Partner and Family Violence
- Immunotherapy and Immune Responses
- Reproductive Health and Technologies
- Genital Health and Disease
- Maternal Mental Health During Pregnancy and Postpartum
- Reproductive tract infections research
- Adolescent Sexual and Reproductive Health
- Hormonal and reproductive studies
- Menstrual Health and Disorders
- Breastfeeding Practices and Influences
- Ovarian function and disorders
- Sexual function and dysfunction studies
- Sex work and related issues
- Homicide, Infanticide, and Child Abuse
- Syphilis Diagnosis and Treatment
- Neuroendocrine regulation and behavior
- Demographic Trends and Gender Preferences
- Grief, Bereavement, and Mental Health
- LGBTQ Health, Identity, and Policy
- International Human Rights and Reproductive Law
Universidade Federal do Paraná
1996-2024
Hospital de Clínicas Universidade Federal do Paraná
1989-2019
Centro de Reprodução Humana Prof. Franco Junior
2005
Human papillomavirus (HPV) causes cervical, vulvar, and vaginal cancers, precancerous dysplasia, genital warts. We report data for the longest efficacy evaluation to date of a prophylactic HPV vaccine. In total, 552 women (16-23 years) were enrolled in randomised, placebo-controlled study quadrivalent 6/11/16/18 L1 virus-like-particle vaccine with vaccination at months 0, 2, 6. At regular intervals through 3 years, subjects underwent gynaecologic examination, cervicovaginal sampling DNA,...
A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously quadrivalent (HPV6/11/16/18; qHPV) vaccine. Efficacy, immunogenicity, and safety outcomes were assessed in Latin American participants enrolled 2 international studies 9vHPV vaccine, including a randomized, double-blinded, controlled with qHPV efficacy, study young women aged 16–26 years, an immunogenicity girls boys 9–15 years. Participants (N=5312) received...
This was an open-label multicenter study to compare the cycle control and effect on well-being of two oral contraceptives containing gestodene one desogestrel. A total 2419 healthy women ≤ 41 years age were randomized receive monophasic (Minulet®; n = 806, mean 24.5 years), triphasic (Tri-Minulet®; 808, 24.6 years) or desogestrel (Mercilon®; 805, years). Subjects participate in for up 13 treatment cycles. modified Moos Menstrual Distress Questionnaire used evaluate menstrual symptoms assess...
AbstractObjective To assess the contraceptive efficacy, cycle control and acceptability of two monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 desogestrel or 75 gestodene.Method In a randomized, open-label, six-cycle, group-comparative, multicenter study performed in Brazil, pregnancies, cycle-control parameters, incidence side-effects presence severity acne vulgaris were assessed, blood pressure body weight measured at pretreatment after one, three six...
OBJETIVO: avaliar a morbidade e mortalidade neonatais relacionadas à idade materna igual ou superior 35 anos. MÉTODOS: de 2.377 nascimentos em um ano, 316 (13,6%) eram gestantes com As selecionadas foram comparadas mulheres entre 20 29 anos, randomicamente 1170 delas (49,2%). Foram incluídas gestacional acima 22 semanas recém nascido (RN) 500 g. excluídos 14 gemelares. Para consideradas as seguintes variáveis: índice Apgar, peso ao nascer, malformações congênitas, adequação do nascer...
Objetivos: analisar as características sociodemográficas das mulheres vítimas de violência sexual, avaliar a experiência sexual prévia, pesquisar utilização métodos anticoncepcionais por ocasião da e observar o período tempo desde agressão até atendimento hospitalar. Métodos: foram analisados os dados 117 fichas pré-codificadas, um total 134 atendimentos. As utilizadas no na Maternidade do Hospital Clínicas Curitiba agosto 1998 junho 2000. Resultados: idade variou 5 49 anos, sendo que metade...
To compare the bleeding pattern in women using ethinylestradiol 20 mcg/drospirenone 3 mg (EE mcg/DRSP mg) a 24/4-day cyclic regimen with an extended regimen. Unexpected bleeding/spotting group was managed by allowing 4-day hormone-free interval (HFI).This randomized, prospective, open-label, multicenter study. Participants (N = 348) were randomized to receive EE either (EE/DRSPes group) or (EE/DRSP24/4 and followed for 168 days. In EE/DRSPes group, HFI allowed whenever unexpected persisted...
Buscou-se identificar o grau de adesão dos hospitais referência ao Protocolo atendimento às mulheres em situação violência sexual no Paraná-Brasil, entre 2009 e 2015, associando aos perfis sociodemográficos categorias adesão. Estudo observacional transversal, população composta por todas as sexual, atendidas 28 Hospitais do Paraná. Analisaram-se dez itens sobre a taxa adesão: desde acolhimento, profilaxias, até encaminhamentos posteriores trauma. Encontrou-se que todos os fizeram agudo...
Aim: There is not much information about breast health in transgender (transexual) persons given the historical stigma that this population suffers. This research aimed to describe imaging patterns (trans) women and men had been using gender affirmation hormone treatment for at least 3 years.Material methods: In observational, cross-sectional study, 67 individuals (34 trans 33 men) mammography ultrasound performed. We also classified findings by American College of Radiology – Breast Imaging...
Introdução: A laqueadura tubária é um método definitivo de contracepção, utilizado por quarto das mulheres brasileiras. Nos ambulatórios infertilidade conjugal com certa frequência, são atendidas pacientes que solicitam a reversão cirúrgica da laqueadura, diferentes razões. Objetivo: Avaliar prevalência consultas essa causa, as características sócio-demográficas dessas e razões levam pedir do procedimento. Métodos: Estudo retrospectivo analisando os prontuários médicos consultaram nos...
A low-dose monophasic oral contraceptive containing 75μg of gestodene and 30μg ethinylestradiol was evaluated for reliability, cycle control tolerability. The study designed as a multicenter, open-label trial involved total 285 women, aged 18 to 35 years, in nine centers, over six cycles. Contraceptive reliability good there were no pregnancies. Cycle excellent, demonstrated by the decline incidence breakthrough bleeding spotting, culminating their eventual absence end 6. Amenorrhea did not...